IHS Chemical Week

Chemical Week Magazine :: Companies

Amyris Sets Stage for Start-Up

6:58 AM MDT | November 4, 2011 | —REBECCA COONS

Downstream Deals in Place; Commercial-scale Plants Come Online in 2012 The past year has been a critical one for synthetic biology firm Amyris (Emeryville, CA), as the newly public firm ramps up production of farnesene, a versatile C15 hydrocarbon that is the company’s first commercial product. Farnesene, which Amyris trade named Biofene, can be used as a platform chemical for producing fuels, polymers, and a number of specialty chemicals. Farnesene was not the company’s initial development target, however. Amyris originally set out in 2003 to develop yeast...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa